Note: Enrolling in this course does not register you for the live event. Please register here to attend the event on May 7 from 2-3 pm ET.

Capitalize on the growing demand for personalized care with a deep dive into hormone replacement therapy (HRT). Led by Sara Hover, RPh, FAARM, this session unpacks the shift toward compounded bioidentical hormone therapy (cBHT) and what it means for clinical practice and patient expectations. Revisit the evolving evidence—from the Women's Health Initiative to the latest FDA updates—while sharpening your understanding of hormone physiology and symptom management. Walk away with dosing strategies and a roadmap to integrate HRT services into your practice for both clinical impact and business growth.

Price

Members - Free

Non-Members - Free


Learning Objectives

1. Differentiate between conventional hormone therapy and compounded bioidentical hormone therapy (cBHT).
2. Summarize the clinical evidence, safety considerations, and evolving guidance, including insights from the Women's Health Initiative and FDA.
3. Identify clinical considerations for hormone replacement therapy in managing peri-menopausal and menopausal symptoms.

04. Speaker(s)

Sara Hover, RPh, FAARM, Director of Clinical Services, PCCA

05. Speaker Disclosure Statement

Sara Hover has a relationship with PCCA.

07. Pharmacist ACPE UAN#

0207-0000-26-213-L07-P

08. Pharmacy Technician ACPE UAN#

0207-0000-26-213-L07-T

09. Contact Hours

1.0

10. Activity Learning Type

Knowledge Based

ACPE Statement

NCPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program will provide 1.0 contact hours (0.1 CEUs) of continuing pharmacy education credit.

Activity Type

Live

Instructions for Participation

To receive a certificate of completion that indicates your eligibility for continuing education credit, you must:

  1. Register for the webinar via zoom and attend at the scheduled time.
  2. Obtain and claim an attendance code for this activity.

Interest

  • Law/Regulatory
  • Compounding

Software Requirements

Google Chrome (Latest Version) – Recommended Browser

Microsoft Edge (Latest Version)

Firefox (Latest Version)

Safari (Latest Version)

Adobe Acrobat Reader *REQUIRED TO VIEW PRINTABLE VERSION OF ANY PDF FILES*

Target Audience

Pharmacists and Pharmacy Technicians

Course Duration

1 hour 0 minutes

#Sessions:Starts:Ends:Location:
1

Opportunities in Hormone Replacement Therapy, Part 1: Clinical Essentials and Business Strategies

Capitalize on the growing demand for personalized care with a deep dive into hormone replacement therapy (HRT). Led by Sara Hover, RPh, FAARM, this session unpacks the shift toward compounded bioidentical hormone therapy (cBHT) and what it means for clinical practice and patient expectations. Revisit the evolving evidence—from the Women’s Health Initiative to the latest FDA updates—while sharpening your understanding of hormone physiology and symptom management. Walk away with dosing strategies and a roadmap to integrate HRT services into your practice for both clinical impact and business growth.
--
--
Zoom
Zoom, Virtual, Virginia, USA
Virtual
Virginia
USA
* times shown in the time of the location
Overview
Image of Course
Type:NCPA Live CE
Credits:2
Credit Categories
Learning Time:1h  
Credits

The following credits are available upon completion of these activities.

Total credits:  2
Key Dates
Starts:05/07/2026
Enrollment:Prior to  07/06/2026
Enrollment